Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy-Reference-Cited by-同舟云学术

Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy

Published:2019-12-11 Issue:2 Volume:30 Page:
ISSN:1052-9276
Container-title:Reviews in Medical Virology
language:en
Short-container-title:Rev Med Virol

Author:

Hakim Mohamad S.¹^ORCID,Rahmadika Nofri²,Jariah Rizka O. A.³^ORCID

Affiliation:

1. Department of Microbiology, Faculty of Medicine, Public Health and NursingUniversitas Gadjah Mada Yogyakarta Indonesia

2. Infectious Disease Research Center, Faculty of MedicineUniversitas Padjadjaran Bandung Indonesia

3. Department of Health Science, Faculty of Vocational StudiesUniversitas Airlangga Surabaya Indonesia

Funder

Direktorat Jenderal Pendidikan Tinggi

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/rmv.2094

Reference137 articles.

1. Molecular and cellular insights into T cell exhaustion

2. Human T Cell Development, Localization, and Function throughout Life

3. Understanding Subset Diversity in T Cell Memory

4. HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help

5. Inhibitory receptor molecules in chronic hepatitis B and C infections: novel targets for immunotherapy?

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in understanding T cell activation and exhaustion during HBV infection;Virologica Sinica;2023-12

2. Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk;Immunity & Ageing;2023-11-17

3. Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity;Frontiers in Cellular and Infection Microbiology;2023-06-22

4. Immune checkpoints on T and NK cells in the context of HBV infection: Landscape, pathophysiology and therapeutic exploitation;Frontiers in Immunology;2023-03-28

5. Heterogeneity of immune control in chronic hepatitis B virus infection: Clinical implications on immunity with interferon-α treatment and retreatment;World Journal of Gastroenterology;2022-10-21